Ghrelin signaling in heart remodeling of adult obese mice

Peptides

Volumn 35, Issue 1, 2012, Pages 65-73

  Lacerda Miranda, Glauciane ^a   Soares, Vivian M ^a   Vieira, Anatalia K G ^a   Lessa, Juliana G ^a   Rodrigues Cunha, Alessandra C S ^a   Cortez, Erika ^a   Garcia Souza, Erica P ^a   Moura, Anibal S ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

AKT; GHSR 1a; Heart; Overnutrition; PI3K

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HORMONE ACTION; HORMONE BLOOD LEVEL; HYPERGLYCEMIA; MALE; MOUSE; NONHUMAN; OBESITY; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADENYLATE KINASE; ANIMALS; ANIMALS, SUCKLING; BLOOD GLUCOSE; CELL SIZE; FEMALE; GENE EXPRESSION; GHRELIN; HEART VENTRICLES; INTRA-ABDOMINAL FAT; MALE; MICE; MYOCYTES, CARDIAC; OBESITY; ORGAN SIZE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, GHRELIN; VENTRICULAR REMODELING; WEIGHT GAIN;

MUS;

EID: 84859788175     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.02.025     Document Type: Article

References (56)

1. Allard MF, Parsons HL, Saeedi R, Wambolt RB, Brownsey R. AMPK and metabolic adaptation by the heart to pressure overload. Am J Physiol 2007;292:H140-8. (Pubitemid 46115922)
2. Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, et al. AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 2004;279:12005-8. (Pubitemid 38445761)
3. Barazzoni Rea. Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab 2005;288:E228-35.
4. Barker JL, Olsen LW, Sorensen TIA. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007:357.
5. Bayne K. Revised guide for the care and use of laboratory animals available. American Physiological Society. Physiologist 1996;39(199):208-11.
6. Beiras-Fernandez A, Kreth S, Weis F, Ledderose C, Pottinger T, Dieguez C, et al. Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure. Peptides 2010;31:2222-8.
7. Berenson GS, Srinivasan SR, Bao W, Newman 3rd WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998;338:1650-6. (Pubitemid 28267909)
8. Castaneda TR, Tong J, Datta R, Culler M, Tschop MH. Ghrelin in the regulation of body weight and metabolism. Front Neuroendocrinol 2010;31:44-60.
9. Cunha AC, Pereira RO, Pereira MJ, Soares Vde M, Martins MR, Teixeira MT, et al. Long-term effects of overfeeding during lactation on insulin secretion-the role of GLUT-2. J Nutr Biochem 2009;20:435-42.
10. DelParigi A, Tschop M, Heiman ML, Salbe AD, Vozarova B, Sell SM, et al. High circulating ghrelin: a potential cause for hyperphagia and obesity in praderwilli syndrome. J Clin Endocrinol Metab 2002;87:5461-4. (Pubitemid 36034344)
11. Dietz WH. Critical periods in childhood for the development of obesity. Am J Clin Nutr 1994;59:955-9. (Pubitemid 24138364)
12. Dzamko N, van Denderen BJ, Hevener AL, Jorgensen SB, Honeyman J, Galic S, et al. AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J Biol Chem 2010;285:115-22.
13. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002;87:2988.
14. Grossini E, Molinari C, Mary DA, Ghigo E, Bona G, Vacca G. Intracoronary ghrelin infusion decreases coronary blood flow in anesthetized pigs. Endocrinology 2007;148:806-12. (Pubitemid 46143180)
15. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 2005;280:29060-6.
16. Iglesias MJ, Pineiro R, Blanco M, Gallego R, Dieguez C, Gualillo O, et al. Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 2004;62:481-8. (Pubitemid 38648962)
17. Jaswal JS, Gandhi M, Finegan BA, Dyck JR, Clanachan AS. Effects of adenosine on myocardial glucose and palmitate metabolism after transient ischemia: role of 5′-AMP-activated protein kinase. Am J Physiol 2006;291:H1883-92. (Pubitemid 44497696)
18. Jeffery PLHA, Chopin LK. The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytokine Growth Factor Rev 2003;14:113-22. (Pubitemid 36389525)
19. Kim SK, Novak RF. The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol Ther 2007;113:88-120. (Pubitemid 44969928)
20. Kleinz MJ, Maguire JJ, Skepper JN, Davenport AP. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res 2006;69:227-35. (Pubitemid 41814824)
21. Klueh U, Liu Z, Cho B, Ouyang T, Feldman B, Henning TP, et al. Continuous glucose monitoring in normal mice and mice with prediabetes and diabetes. Diabetes Technol Ther 2006;8:402-12. (Pubitemid 46100534)
22. Kojima MHH, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth hormone-releasing acylated peptide from stomach. Nature 1999;402:656-60. (Pubitemid 129516334)
23. Kola Bea. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem 2005;280:25196-201.
24. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
25. Mandarim-de-Lacerda CA. Stereological tools in biomedical research. An Acad Bras Cienc 2003;75:469-86. (Pubitemid 37445844)
26. Martins MR, Vieira AK, de Souza EP, Moura AS. Early overnutrition impairs insulin signaling in the heart of adult Swiss mice. J Endocrinol 2008;198:591-8.
27. Moazed B, Quest D, Gopalakrishnan V. Des-acyl ghrelin fragments evoke endothelium-dependent vasodilatation of rat mesenteric vascular bed via activation of potassium channels. Eur J Pharmacol 2009;604:79-86.
28. Moreira AS, Teixeira Teixeira M, da Silveira Osso F, Pereira RO, de Oliveira Silva-Junior G, Garcia de Souza EP, et al. Left ventricular hypertrophy induced by overnutrition early in life. Nutr Metab Cardiovasc Dis 2009;19:805-10.
29. Nagaya N, Uematsu M, Kojima M, Date Y, Nakazato M, Okumura H, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 2001;104:2034-8. (Pubitemid 33027043)
30. Nakagawa E, Nagaya N, Okumura H, Enomoto M, Oya H, Ono F, et al. Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone- releasing peptide: responses to the intravenous and oral administration of glucose. Clin Sci (Lond) 2002;103:325-8. (Pubitemid 35007225)
31. Ofir M, Arad M, Porat E, Freimark D, Chepurko Y, Vidne BA, et al. Increased glycogen stores due to gamma-AMPK overexpression protects against ischemia and reperfusion damage. Biochem Pharmacol 2008;75:1482-91.
32. Okumura HNN, Enomoto M, Nakagawa E, Oya H, Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharm 2002;39:779-83. (Pubitemid 34538806)
33. Papotti MGC, Cassoni P, Catapano F, Deghenghi R, Ghigo E, et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000;85:3803-7.
34. Pemberton CJ, Tokola H, Bagi Z, Koller A, Pontinen J, Ola A, et al. Ghrelin induces vasoconstriction in the rat coronary vasculature without altering cardiac peptide secretion. Am J Physiol Heart Circ Physiol 2004;287:H1522-9. (Pubitemid 39313255)
35. Plagemann A, Heidrich I, Gotz F, Rohde W, Dorner G. Obesity and enhanced diabetes and cardiovascular risk in adult rats due to early postnatal overfeeding. Exp Clin Endocrinol 1992;99:154-8.
36. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003;52:2546-53. (Pubitemid 37210544)
37. Rodrigues AL, De Souza EP, Da Silva SV, Rodrigues DS, Nascimento AB, Barja-Fidalgo C, et al. Low expression of insulin signaling molecules impairs glucose uptake in adipocytes after early overnutrition. J Endocrinol 2007;195:485-94.
38. Rodriguez A, Gomez-Ambrosi J, Catalan V, Becerril S, Sainz N, Gil MJ, et al. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome. J Hypertens 2010;28:560-7.
39. Russell III RR, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 2004;114:495-503. (Pubitemid 39572099)
40. Rutter GA, Da Silva Xavier G, Leclerc I. Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 2003;375:1-16. (Pubitemid 37255376)
41. Schmitto JD, Mokashi SA, Lee LS, Popov AF, Coskun KO, Sossalla S, et al. Large animal models of chronic heart failure (CHF). J Surg Res 2011;166:131-7.
42. Schultze SM, Hemmings BA, Niessen M, Tschopp O. PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Rev Mol Med 2012;14:e1.
43. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 2004;101:3329-35. (Pubitemid 38338195)
44. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005;115:2108-18. (Pubitemid 41134152)
45. Soares VM, Garcia-Souza EP, Lacerda-Miranda G, Moura AS. Early life overfeeding decreases acylated ghrelin circulating levels and upregulates GHSR1a signaling pathway in white adipose tissue of obese young mice. Regul Pept 2012;174:6-11.
46. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001;50:707-9. (Pubitemid 32242624)
47. Vestergaard ET, Gormsen LC, Jessen N, Lund S, Hansen TK, Moller N, et al. Ghrelin infusion in humans induces acute insulin resistance and lipolysis independent of growth hormone signaling. Diabetes 2008;57:3205-10.
48. Wainwright PE. Issues of design and analysis relating to the use of multiparous species in developmental nutritional studies. J Nutr 1998;128:661-3.
49. Weibel ER. Stereological methods. Practical methods for biological morphometry. London/New York/Toronto/Sydney/San Francisco: Academic Press; 1979.
50. Weis F, Beiras-Fernandez A, Sodian R, Kaczmarek I, Reichart B, Beiras A, et al. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. J Mol Cell Cardiol 2010;48:1187-93.
51. Weiss RDJ, Burger TS, Tamborlane WV, Takasali SE, Yeckel CW, Allen K, et al. Obesity and metabolic syndrome in children and adolescents. N Engl J Med 2004:359.
52. Wiley KE, Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 2002;136:1146-52. (Pubitemid 34970066)
53. Xu X, Jhun BS, Ha CH, Jin ZG. Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology 2008;149:4183-92.
54. Yatscoff MA, Jaswal JS, Grant MR, Greenwood R, Lukat T, Beker DL, et al. Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart. Pediatr Res 2008;64:643-7.
55. Yin FC, Rakusan SH, Weisfeldt K, Lakatta EG ML. Use of tibial length to quantify cardiac hypertrophy: application in the aging rat. Am J Physiol 1982;243:H941-7. (Pubitemid 13169525)
56. Zhang G, Yin X, Qi Y, Pendyala L, Chen J, Hou D, et al. Ghrelin and cardiovascular diseases. Curr Cardiol Rev 2010;6:62-70.